BRIMAR THERAPEUTICS
Developed Blood Substitute already cleared for K-9 by FDA. Need funding for manufacturing to place products on Market
BriMar Therapeutics has developed, patented, tested and has FDA CLEARANCE to market a Bloodless and animal protein clear Blood Substitute. This first clearance is approved for animals. K-9 has been a major part of testing. This funding with help BriMar Therapeutics manufacturer and place product on the market. This market has the potential of reaching $85b within five years. In the first three years BriMar can.be $5m profitable in Three years. Joe Fischer has invested $1.5mm of personal money. Customers include individual VMD and IVECC hospitals and Doctors. 1.5 million in the first year!
Fundraise Details
Fundraise DetailsThis section is only visible to registered investors. Log in or register as an accredited investor to view.
Ready to Ask For Funding for your company?
Post a Funding RequestKey Facts
- Industry
- {{model.industry | ffIndustry}}
- Location
- {{model.city_state}}
- Year Founded
- {{model.year_founded}}
- Monthly Income
- {{model.monthly_income | ffIncome}}
- Website
- {{model.homepage_url}}